This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at http://www.bbc.co.uk/news/health-31986446

The article has changed 10 times. There is an RSS feed of changes available.

Version 2 Version 3
Meningitis B vaccine needed urgently, campaigners say Meningitis B vaccine needed urgently, campaigners say
(35 minutes later)
Delays in introducing a vaccine that protects against a deadly form of meningitis are putting the lives of children at risk, campaigners say.Delays in introducing a vaccine that protects against a deadly form of meningitis are putting the lives of children at risk, campaigners say.
A year ago, expert advisers for the government recommended the meningitis B vaccine be given to babies from two months old across the UK on the NHS.A year ago, expert advisers for the government recommended the meningitis B vaccine be given to babies from two months old across the UK on the NHS.
But a cost-effective price has not yet been agreed with the manufacturers.But a cost-effective price has not yet been agreed with the manufacturers.
The Department of Health said it wanted to see the vaccine introduced as soon as possible.The Department of Health said it wanted to see the vaccine introduced as soon as possible.
The manufacturers, GSK, said they would be continuing discussions with the government.The manufacturers, GSK, said they would be continuing discussions with the government.
Meanwhile, meningitis charities are calling for urgent action from the prime minister and the health secretary to conclude negotiations and introduce the vaccine.Meanwhile, meningitis charities are calling for urgent action from the prime minister and the health secretary to conclude negotiations and introduce the vaccine.
Long-term problemsLong-term problems
Meningitis is a bacterial infection that usually affects children under the age of one.Meningitis is a bacterial infection that usually affects children under the age of one.
There are about 1,870 cases of meningitis B each year in the UK.There are about 1,870 cases of meningitis B each year in the UK.
Symptoms include a high fever with cold hands and feet, confusion, vomiting and headaches.Symptoms include a high fever with cold hands and feet, confusion, vomiting and headaches.
With early diagnosis and antibiotic treatment, most children will make a full recovery.With early diagnosis and antibiotic treatment, most children will make a full recovery.
But it is fatal in one in 10 cases - and about one in four of those who survive is left with long-term problems, such as amputation, deafness, epilepsy and learning difficulties.But it is fatal in one in 10 cases - and about one in four of those who survive is left with long-term problems, such as amputation, deafness, epilepsy and learning difficulties.
A Department of Health spokesman said: "We are very clear that we want to see this vaccine introduced as soon as possible to help protect children from this devastating disease.A Department of Health spokesman said: "We are very clear that we want to see this vaccine introduced as soon as possible to help protect children from this devastating disease.
"The JCVI (Joint Committee on Vaccination and Immunisation) recommended that a MenB vaccine be introduced, but only at a cost-effective price - below the price published by the manufacturer. We need to make sure NHS funds are used as effectively as possible and negotiations are continuing.""The JCVI (Joint Committee on Vaccination and Immunisation) recommended that a MenB vaccine be introduced, but only at a cost-effective price - below the price published by the manufacturer. We need to make sure NHS funds are used as effectively as possible and negotiations are continuing."
GSK said the price of one dose of Bexsero - the vaccine in question - was £75. GSK said the list price of one dose of Bexsero - the vaccine in question - was £75.
The company recently acquired Bexsero as part of a recent transaction with Novartis.The company recently acquired Bexsero as part of a recent transaction with Novartis.
What is meningitis?What is meningitis?
• Meningitis is an infection of the meninges - the membrane that surrounds the brain and spinal cord• Meningitis is an infection of the meninges - the membrane that surrounds the brain and spinal cord
• Meningococcal bacteria are common and carried harmlessly in the nose or throat by about one in 10 people• Meningococcal bacteria are common and carried harmlessly in the nose or throat by about one in 10 people
• They are passed on through close contact• They are passed on through close contact
• Anyone can get meningitis but babies and young children are most vulnerable• Anyone can get meningitis but babies and young children are most vulnerable
• Symptoms include a high fever with cold hands and feet, agitation, confusion, vomiting and headaches.• Symptoms include a high fever with cold hands and feet, agitation, confusion, vomiting and headaches.
Q&A: Meningitis B vaccineQ&A: Meningitis B vaccine
'Limited budget''Limited budget'
Sue Davie, from charity Meningitis Now, said: "Too many of our children are needlessly dying or being left disabled due to this lethargic bureaucracy and this government's inability to conclude a deal.Sue Davie, from charity Meningitis Now, said: "Too many of our children are needlessly dying or being left disabled due to this lethargic bureaucracy and this government's inability to conclude a deal.
"How can it take eight months for two parties to negotiate on one item, especially when that item is a vaccine that will save lives and prevent disability?""How can it take eight months for two parties to negotiate on one item, especially when that item is a vaccine that will save lives and prevent disability?"
She said the UK had one of the world's highest meningitis B rates, killing more of the country's under-fives than any other infectious illness.She said the UK had one of the world's highest meningitis B rates, killing more of the country's under-fives than any other infectious illness.
Prof Matthew Snape, a consultant in general paediatrics and vaccinology at the Children's Hospital, Oxford, told BBC Breakfast it was "very frustrating for everyone involved" that negotiations were still under way.Prof Matthew Snape, a consultant in general paediatrics and vaccinology at the Children's Hospital, Oxford, told BBC Breakfast it was "very frustrating for everyone involved" that negotiations were still under way.
Prof Snape, who works with the Oxford Vaccine Group, which conducted clinical trials on the vaccine, said: "The published suggested cost effective price is between £3 and £7 per dose and the listed price is around £75 a dose, so there's a big discrepancy there and there has been a year of negotiation.Prof Snape, who works with the Oxford Vaccine Group, which conducted clinical trials on the vaccine, said: "The published suggested cost effective price is between £3 and £7 per dose and the listed price is around £75 a dose, so there's a big discrepancy there and there has been a year of negotiation.
"It's very frustrating for everyone involved. Seeing children come in with Men B disease - that's clearly very frustrating.""It's very frustrating for everyone involved. Seeing children come in with Men B disease - that's clearly very frustrating."
But he added: "We can't ignore health economics.But he added: "We can't ignore health economics.
"There's a limited budget in the NHS and that has to be used in the most effective way possible.""There's a limited budget in the NHS and that has to be used in the most effective way possible."
Dr Ian Maconichie, from the Royal College of Paediatrics and Child Health, said a decision was needed urgently.Dr Ian Maconichie, from the Royal College of Paediatrics and Child Health, said a decision was needed urgently.
"One year on, we appeal that a decision is made imminently, so should the vaccine be introduced, it can begin to save children's lives and spare some from severe preventable disability as soon as possible.""One year on, we appeal that a decision is made imminently, so should the vaccine be introduced, it can begin to save children's lives and spare some from severe preventable disability as soon as possible."
There are several different strains of meningitis infection.There are several different strains of meningitis infection.
Vaccines are already given to babies in the UK to protect against meningitis C.Vaccines are already given to babies in the UK to protect against meningitis C.
Last week, Public Health England announced that teenagers would soon be vaccinated against meningitis W after a steep rise in the number of cases.Last week, Public Health England announced that teenagers would soon be vaccinated against meningitis W after a steep rise in the number of cases.
Prof Snape said the meningitis B vaccine would also protect against meningitis W however, which was another reason he believed it should be introduced.Prof Snape said the meningitis B vaccine would also protect against meningitis W however, which was another reason he believed it should be introduced.
The parents of 16-month-old Harmonie-Rose Allen, who lost all her limbs after contracting meningitis B said they did not want other families to suffer as they had.The parents of 16-month-old Harmonie-Rose Allen, who lost all her limbs after contracting meningitis B said they did not want other families to suffer as they had.
Her mother Freya Hall said of the vaccine: "I just don't know why it's not in yet. I am so upset that it's not brought in."Her mother Freya Hall said of the vaccine: "I just don't know why it's not in yet. I am so upset that it's not brought in."
Are you affected by the issues in this story? You can share your experiences by emailing haveyoursay@bbc.co.uk.
If you would be happy to speak further to a BBC journalist, please include a contact telephone number.
Have your say